CranioSense is a clinical stage startup on a mission to unlock the hidden parameters of brain health by enabling on demand neurological insight and treatment across the neurological care spectrum. IPASS (Intracranial Pressure Assessment and Screening System) is the first product that we are bringing to the market to realize that mission, a noninvasive medical device for initial diagnosis and continuous monitoring of intracranial hypertension, the point at which ICP becomes clinically unacceptable. CranioSense is a subsidiary of Vivonics